Health and economic burden of sugar-sweetened beverages consumption in Brazil.
Lucas PerelliAndrea AlcarazCid Manso de Mello ViannaNatalia EspinolaFederico Rodriguez CairoliAriel Esteban BardachAlfredo PalaciosDario BalanPaula JohnsFederico AugustovskiAndrés Pichón-RivierePublished in: Cadernos de saude publica (2023)
Sugar-sweetened beverages (SSBs) are a major source of added sugar and are associated with noncommunicable diseases (NCDs) such as obesity and diabetes. This study assessed the impact of SSBs consumption on disease burden in Brazil, including deaths, disability-adjusted life years (DALYs), and healthcare costs. A 3-stage methodology was used to assess the direct effects of SSBs on diabetes, cardiovascular diseases, and body mass index (BMI), along with the influence of BMI on disease incidence. These assessments were then used to estimate the economic and health burden using population-attributable factors. Results showed that 2.7% and 11% of adult and children overweight/obesity cases were attributable to SSBs, respectively. SSBs consumption in Brazil led to 1,814,486 cases, 12,942 deaths, 362,088 DALYs, and USD 2,915.91 million in medical costs related to diabetes, cardiovascular diseases, oncological diseases, and other NCDs. Urgent implementation of public policies is crucial to address the consumption of SSBs, recognized as a key risk factor for NCDs.
Keyphrases
- healthcare
- cardiovascular disease
- weight gain
- body mass index
- type diabetes
- weight loss
- public health
- glycemic control
- insulin resistance
- metabolic syndrome
- risk factors
- health information
- primary care
- physical activity
- multiple sclerosis
- high fat diet induced
- young adults
- cardiovascular events
- cardiovascular risk factors
- rectal cancer
- prostate cancer
- minimally invasive
- radical prostatectomy
- health insurance
- health promotion
- drug induced
- adverse drug
- adipose tissue